The Nicotine-Curcumin Paradigm in Neuroprotection and Neurotherapy for Alzheimer's Disease
Author Information
Author(s): Kumar Pradeep, Pillay Viness, Choonara Yahya E., Modi Girish, Naidoo Dinesh, du Toit Lisa C.
Primary Institution: University of the Witwatersrand
Hypothesis
Can a combination of curcumin and glycosylated nornicotine provide neuroprotective effects against Alzheimer's disease through in silico modeling?
Conclusion
The study suggests that curcumin and glycosylated nornicotine can form a potential neuroprotective and neurotherapeutic combination against aggregated Aβ that causes Alzheimer's disease.
Supporting Evidence
- Curcumin has been shown to inhibit Aβ aggregation and reduce amyloid levels.
- Glycosylated nornicotine may alter the neurotoxicity of soluble aggregates.
- The combination of curcumin and glycosylated nornicotine demonstrated synergistic effects in reducing Aβ aggregation.
- In silico methods provided predictive models for neuroprotective interactions.
- Artificial Neural Networks identified curcumin and glycosylated nornicotine as significant neuroprotective entities.
Takeaway
This study looks at how two substances, curcumin and glycosylated nornicotine, might work together to help protect the brain from Alzheimer's disease.
Methodology
The study used in silico modeling, molecular mechanics simulations, and artificial neural networks to analyze the interactions of neuroprotective entities with amyloid beta protein.
Limitations
The study is based on in silico models and may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website